Skip to Content

Fresenius SE & Co KGaA FRE3

Morningstar Rating
€29.28 −0.52 (1.75%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FRE3 is trading at a 658% premium.
Price
€29.29
Fair Value
€47.56
Uncertainty
High
1-Star Price
€26.79
5-Star Price
€65.75
Economic Moat
Fhpnsm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FRE3 is a good fit for your portfolio.

News

Trading Information

Previous Close Price
€29.80
Day Range
€29.2829.98
52-Week Range
€19.7347.58
Bid/Ask
€0.00 / €0.00
Market Cap
€16.49 Bil
Volume/Avg
7,282 / 7,640

Key Statistics

Price/Earnings (Normalized)
6.81
Price/Sales
0.60
Dividend Yield (Trailing)
3.14%
Dividend Yield (Forward)
Total Yield
3.14%

Company Profile

Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Large Value
Total Number of Employees
190,863

Competitors

Valuation

Metric
FRE3
ICUI
DVA
Price/Earnings (Normalized)
6.8119.0015.38
Price/Book Value
0.851.3413.37
Price/Sales
0.601.221.06
Price/Cash Flow
14.0510.076.57
Price/Earnings
FRE3
ICUI
DVA

Financial Strength

Metric
FRE3
ICUI
DVA
Quick Ratio
0.600.921.30
Current Ratio
1.352.611.43
Interest Coverage
2.85−0.054.36
Quick Ratio
FRE3
ICUI
DVA

Profitability

Metric
FRE3
ICUI
DVA
Return on Assets (Normalized)
2.43%3.32%6.99%
Return on Equity (Normalized)
7.80%6.94%118.17%
Return on Invested Capital (Normalized)
4.23%5.84%10.75%
Return on Assets
FRE3
ICUI
DVA
See how this stock stacks up to its competitors with Morningstar Investor

Medical Care Facilities Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
HCA Healthcare Inc
HCA
DkvycdwwWsmcjl$88.4 Bil
Fresenius SE & Co KGaA
FSNUF
Nyrsfqg$17.9 Bil
Fresenius SE & Co KGaA ADR
FSNUY
Jgdtl$17.9 Bil
Tenet Healthcare Corp
THC
FhfkrgmhNtdrj$13.5 Bil
Universal Health Services Inc Class B
UHS
Mvtztj$12.6 Bil
DaVita Inc
DVA
VxbzrfkvgXnsmx$12.4 Bil
Fresenius Medical Care AG
FMCQF
Djcth$12.2 Bil
Fresenius Medical Care AG ADR
FMS
VzhcHpxdfz$12.2 Bil
Bangkok Dusit Medical Services PCL Units Non-Voting Depository Receipt
BDUUF
Ksswy$11.8 Bil
AMN Healthcare Services Inc
AMN
DprmdmpMhvyfcz$2.1 Bil

Sponsor Center